Lorenzo Daniele

Summary

Affiliation: University of Turin
Country: Italy

Publications

  1. ncbi Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    J Thorac Oncol 4:684-8. 2009
  2. ncbi Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases
    Paola Cassoni
    Department of Biomedical Sciences and Oncology, University of Turin, Turin, Italy
    Histopathology 55:20-7. 2009
  3. ncbi Neoadjuvant chemo-radiotherapy for locally advanced esophageal cancer: a monocentric study
    Marina Schena
    Department of Onco Hematology, Oncology Unit, San Giovanni Battista Hospital, Turin, Italy
    Tumori 98:451-7. 2012
  4. ncbi Gefitinib (ZD1839): therapy in selected patients with non-small cell lung cancer (NSCLC)?
    Diego Dongiovanni
    Medical Oncology, Centro Oncologico Ematologico Subalpino C O E S, Azienda Ospedaliera S Giovanni Battista, Turin, Italy
    Lung Cancer 61:73-81. 2008
  5. ncbi Technical limits of comparison of step-sectioning,immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacarn-fixed tissue
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    J Cell Mol Med 13:4042-50. 2009
  6. ncbi Added value of combined gene and protein expression of CK20 and CEA in non-macroscopically involved lymph nodes of colorectal cancer
    Giuseppe D'Armento
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    Int J Surg Pathol 17:93-8. 2009
  7. ncbi Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    Mol Cancer Ther 6:1223-9. 2007
  8. ncbi Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta
    Marco Prunotto
    Department of Biomedical Science and Human Oncology, University of Turin, Italy
    Lung Cancer 64:244-6. 2009
  9. ncbi Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms
    Enrico Ruffini
    Department of Thoracic Surgery, University of Torino, Torino, Italy
    Ann Thorac Surg 87:365-71; discussion 371-2. 2009
  10. ncbi Columnar cell lesions associated with breast calcifications on vacuum-assisted core biopsies: clinical, radiographic, and histological correlations
    Rebecca Senetta
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    Mod Pathol 22:762-9. 2009

Collaborators

Detail Information

Publications12

  1. ncbi Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    J Thorac Oncol 4:684-8. 2009
    ..Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors are capable of reducing brain and adrenal metastases. However, the EGFR status may be discordant between primary NSCLC and the corresponding metastases...
  2. ncbi Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases
    Paola Cassoni
    Department of Biomedical Sciences and Oncology, University of Turin, Turin, Italy
    Histopathology 55:20-7. 2009
    ..To study caveolin-1 (Cav-1) expression in metastatic lung carcinomas...
  3. ncbi Neoadjuvant chemo-radiotherapy for locally advanced esophageal cancer: a monocentric study
    Marina Schena
    Department of Onco Hematology, Oncology Unit, San Giovanni Battista Hospital, Turin, Italy
    Tumori 98:451-7. 2012
    ....
  4. ncbi Gefitinib (ZD1839): therapy in selected patients with non-small cell lung cancer (NSCLC)?
    Diego Dongiovanni
    Medical Oncology, Centro Oncologico Ematologico Subalpino C O E S, Azienda Ospedaliera S Giovanni Battista, Turin, Italy
    Lung Cancer 61:73-81. 2008
    ....
  5. ncbi Technical limits of comparison of step-sectioning,immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacarn-fixed tissue
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    J Cell Mol Med 13:4042-50. 2009
    ..We believe that only prospective studies with quantitative mRNA analysis of specific metastatic markers on the whole lymph node can elucidate the utility of molecular assessments of SLN...
  6. ncbi Added value of combined gene and protein expression of CK20 and CEA in non-macroscopically involved lymph nodes of colorectal cancer
    Giuseppe D'Armento
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    Int J Surg Pathol 17:93-8. 2009
    ..This approach offers a technological framework for further studies that aim to validate the clinical significance of protein/mRNA expression of tumor markers in colorectal cancer sentinel lymph nodes...
  7. ncbi Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    Mol Cancer Ther 6:1223-9. 2007
    ....
  8. ncbi Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta
    Marco Prunotto
    Department of Biomedical Science and Human Oncology, University of Turin, Italy
    Lung Cancer 64:244-6. 2009
    ..With the limit of experimental findings, our results support a possible future application of imatinib as a candidate molecule in the target therapy of malignant SFTs over-expressing wild-type PDGFR...
  9. ncbi Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms
    Enrico Ruffini
    Department of Thoracic Surgery, University of Torino, Torino, Italy
    Ann Thorac Surg 87:365-71; discussion 371-2. 2009
    ..We examined prevalence, correlations, and prognostic significance of TIL among our patient population of resected lung neoplasms...
  10. ncbi Columnar cell lesions associated with breast calcifications on vacuum-assisted core biopsies: clinical, radiographic, and histological correlations
    Rebecca Senetta
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    Mod Pathol 22:762-9. 2009
    ....
  11. ncbi Anti-HER2 treatment and breast cancer: state of the art, recent patents, and new strategies
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Italy
    Recent Pat Anticancer Drug Discov 4:9-18. 2009
    ..This review will focus on patents that target HER2 in anti-cancer treatment...
  12. ncbi Metastasis of malignant peritoneal epithelioid mesothelioma in endoscopic gastric biopsy: a diagnostic pitfall
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    Int J Surg Pathol 19:217-9. 2011
    ....